The pharmaceutical landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a potential development. Unlike subcutaneous injections, this method offers a less invasive way to administer https://aronhhuf664614.timeblog.net/76849279/glp-1-patches-a-novel-approach-to-diabetes-management